Table 1.
Antibodies
Group | Antibody | Epitope | Dilution
|
Source | |||
---|---|---|---|---|---|---|---|
IB | IF | IHC | ELISA | ||||
Abl | 2411 | c-Abl C-terminus | 1 : 1000 | Santa Cruz | |||
K12 | c-Abl kinase domain | 1 : 2000 | 1 : 4000 | Santa Cruz | |||
pY412 | c-Abl pY412 | 1 : 1000 | Cell Signaling | ||||
Arg | AR19 | Arg N-terminus | 1 : 500 | 1 : 1000 | Peter Davies | ||
AR23 | Abl, Arg N-terminus | 1 : 1000 | Peter Davies | ||||
P-Tyr | 4 G10 | Phospho-tyrosine | 1 : 1000 | 1 : 1000 | 1 : 5000 (tau) | Millipore | |
1 : 1000 (Abl) | |||||||
Neurons | NeuN | NeuN | 1 : 10000 | Millipore | |||
Astrocytes | GFAP | GFAP | 1 : 1000 | 1 : 500 | Invitrogen | ||
Microglia | Iba-1 | Iba-1 | 1 : 1000 | Wako | |||
Tau | DA31 | Tau, 150–190 | Coating 2 μg/ml | Peter Davies | |||
PHF-1 | Tau pS396/pS404 | 1 : 5000 | Peter Davies | ||||
CP13 | Tau pS202 | 1 : 5000 | Peter Davies | ||||
MC-1 | Tau, 5–15, 312–322 | 1 : 200 | Peter Davies | ||||
YP4 | Tau pY394, pS396 | 1 : 100 | Peter Davies | ||||
DA9* | Tau, 102–150 | 1 : 5000 | Peter Davies | ||||
Amyloid | 4G8 | β-amyloid,17–24 | 1 : 1000 | Covance |
Biotinylated.